BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 32350911)

  • 1. Glycomics and glycoproteomics of viruses: Mass spectrometry applications and insights toward structure-function relationships.
    Cipollo JF; Parsons LM
    Mass Spectrom Rev; 2020 Jul; 39(4):371-409. PubMed ID: 32350911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics protocols in glycomics and glycoproteomics.
    Tang H; Mayampurath A; Yu CY; Mechref Y
    Curr Protoc Protein Sci; 2014 Apr; 76():2.15.1-2.15.7. PubMed ID: 24692013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global and site-specific analysis of protein glycosylation in complex biological systems with Mass Spectrometry.
    Xiao H; Sun F; Suttapitugsakul S; Wu R
    Mass Spectrom Rev; 2019 Aug; 38(4-5):356-379. PubMed ID: 30605224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral glycoproteomes: technologies for characterization and outlook for vaccine design.
    Bagdonaite I; Vakhrushev SY; Joshi HJ; Wandall HH
    FEBS Lett; 2018 Dec; 592(23):3898-3920. PubMed ID: 29961944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in mass spectrometry-based glycoproteomics.
    Frost DC; Li L
    Adv Protein Chem Struct Biol; 2014; 95():71-123. PubMed ID: 24985770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycomics-informed glycoproteomic analysis of site-specific glycosylation for SARS-CoV-2 spike protein.
    Rosenbalm KE; Tiemeyer M; Wells L; Aoki K; Zhao P
    STAR Protoc; 2020 Dec; 1(3):100214. PubMed ID: 33377107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards structure-focused glycoproteomics.
    Chernykh A; Kawahara R; Thaysen-Andersen M
    Biochem Soc Trans; 2021 Feb; 49(1):161-186. PubMed ID: 33439247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of N- and O-linked site-specific glycosylation by ion mobility mass spectrometry: State of the art and future directions.
    Girgis M; Petruncio G; Russo P; Peyton S; Paige M; Campos D; Sanda M
    Proteomics; 2024 Jun; 24(12-13):e2300281. PubMed ID: 38171879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycomics, glycoproteomics and the immune system.
    Kolarich D; Lepenies B; Seeberger PH
    Curr Opin Chem Biol; 2012 Apr; 16(1-2):214-20. PubMed ID: 22221852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycomic and glycoproteomic analysis of glycoproteins-a tutorial.
    Shajahan A; Heiss C; Ishihara M; Azadi P
    Anal Bioanal Chem; 2017 Jul; 409(19):4483-4505. PubMed ID: 28585084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mass spectrometry-based glycotope-centric cellular glycomics is the more fruitful way forward to see the forest for the trees.
    Khoo KH
    Biochem Soc Trans; 2021 Feb; 49(1):55-69. PubMed ID: 33492355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable isotope labeling of N-glycosylated peptides by enzymatic deglycosylation for mass spectrometry-based glycoproteomics.
    Kaji H; Isobe T
    Methods Mol Biol; 2013; 951():217-27. PubMed ID: 23296533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Algorithms and design strategies towards automated glycoproteomics analysis.
    Hu H; Khatri K; Zaia J
    Mass Spectrom Rev; 2017 Jul; 36(4):475-498. PubMed ID: 26728195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometric analysis of glycosylated viral proteins.
    Harvey DJ
    Expert Rev Proteomics; 2018 May; 15(5):391-412. PubMed ID: 29707974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Integrated Mass Spectrometry-Based Glycomics-Driven Glycoproteomics Analytical Platform to Functionally Characterize Glycosylation Inhibitors.
    Alvarez MRS; Zhou Q; Grijaldo SJB; Lebrilla CB; Nacario RC; Heralde FM; Rabajante JF; Completo GC
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in mass spectrometric analysis of glycoproteins.
    Banazadeh A; Veillon L; Wooding KM; Zabet-Moghaddam M; Mechref Y
    Electrophoresis; 2017 Jan; 38(1):162-189. PubMed ID: 27757981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What Can N-glycomics and N-glycoproteomics of Cerebrospinal Fluid Tell Us about Alzheimer Disease?
    Gaunitz S; Tjernberg LO; Schedin-Weiss S
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Omics and Computational Glycobiology Reveal Structural Basis for Influenza A Virus Glycan Microheterogeneity and Host Interactions.
    Khatri K; Klein JA; White MR; Grant OC; Leymarie N; Woods RJ; Hartshorn KL; Zaia J
    Mol Cell Proteomics; 2016 Jun; 15(6):1895-912. PubMed ID: 26984886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a combined glycomics and glycoproteomics approach for studying the major glycoproteins present in biofluids: Application to cerebrospinal fluid.
    Goyallon A; Cholet S; Chapelle M; Junot C; Fenaille F
    Rapid Commun Mass Spectrom; 2015 Mar; 29(6):461-73. PubMed ID: 26160412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Technologies for Complex Glycoproteomics and Their Applications to Biology/Disease-Driven Glycoproteomics.
    Narimatsu H; Kaji H; Vakhrushev SY; Clausen H; Zhang H; Noro E; Togayachi A; Nagai-Okatani C; Kuno A; Zou X; Cheng L; Tao SC; Sun Y
    J Proteome Res; 2018 Dec; 17(12):4097-4112. PubMed ID: 30359034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.